er-stress-neurodegeneration

Introduction

Endoplasmic Reticulum Stress In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Endoplasmic reticulum (ER) stress is a central pathological mechanism in [neurodegenerative diseases, triggered when the ^{1Citation2015Open reference} accumulation of unfolded or misfolded proteins in the ER lumen exceeds the organelle’s folding capacity. The ER is the primary site for ^{2Citation2022 · Cell Death & DiseaseOpen reference} synthesis, folding, and post-translational modification of secretory and transmembrane proteins, and its dysfunction activates a complex ^{3''2017Open reference} adaptive signaling network known as the unfolded protein response (UPR). While the endoplasmic-reticulum-stress initially functions as a protective mechanism to ^{4Citation2019Open reference} restore proteostasis, chronic or excessive ER stress shifts the response from adaptive to maladaptive, ultimately triggering apoptotic ^{5Citation2026Open reference} cell death pathways that are particularly devastating in post-mitotic neurons with limited regenerative capacity ^{6Citation2023 · Life SciencesOpen reference 7''Open reference 8Citation2023 · PMID 38159591Open reference 1Citation2015Open reference}. ^{9Citation2025Open reference}

The neurodegenerative diseases most prominently linked to ER stress include alzheimers, parkinsons, als, huntington-pathway, prion-disease, and ftd. Each of these disorders is ^{2Citation2022 · Cell Death & DiseaseOpen reference}0 characterized by the accumulation of specific misfolded proteins—amyloid-beta and tau] in AD, alpha-synuclein ^{2Citation2022 · Cell Death & DiseaseOpen reference}1 in PD, sod1-protein/tdp-43/fus in ALS, huntingtin in HD—that directly or indirectly overwhelm ^{2Citation2022 · Cell Death & DiseaseOpen reference}2 ER protein quality control systems ^{2Citation2022 · Cell Death & DiseaseOpen reference}3 ^{2Citation2022 · Cell Death & DiseaseOpen reference}4.

flowchart TD
    A["Protein Misfolding<br/>ER Stress"] --> B["BiP Dissociation<br/>from Sensors"]

    B --> C{"PERK Pathway"}
    B --> D{"IRE1alpha Pathway"}
    B --> E{"ATF6 Pathway"}

    C --> C1["PERK Oligomerization"]
    C1 --> C2["p-eIF2alpha"]
    C2 --> C3["Global Translation<br/>Repression"]
    C2 --> C4["ATF4 Translation"]
    C4 --> C5["Adaptive Genes<br/>Expression"]
    C5 --> C6["{Prolonged<br/>Stress?}"]
    C6 -->|"Yes"| C7["CHOP Expression"]
    C7 --> C8["Pro-apoptotic<br/>Signaling"]
    C8 --> C9["Apoptosis"]

    D --> D1["IRE1alpha Oligomerization"]
    D1 --> D2["XBP1 Splicing"]
    D2 --> D3["XBP1s Translation"]
    D3 --> D4["Chaperone<br/>Expression"]
    D3 --> D5["ERAD<br/>Enhancement"]

    E --> E1["ATF6 Golgi<br/>Cleavage"]
    E1 --> E2["ATF6f Active<br/>Transcription Factor"]
    E2 --> E3["ER Chaperones<br/>Expression"]
    E2 --> E4["XBP1<br/>Expression"]

    C6 -->|"No"| F["Recovery"]
    D4 --> F
    E3 --> F

    F --> G["Normal Protein<br/>Folding Resumes"]

    %% Color coding: Blue=triggers, Red=pathological, Green=normal/recovery
    style A fill:#0a1929,stroke:#01579b
    style C fill:#0a1929,stroke:#01579b
    style D fill:#0a1929,stroke:#01579b
    style E fill:#0a1929,stroke:#01579b
    style C9 fill:#3b1114,stroke:#c62828,stroke-width:3px
    style C8 fill:#5d3400,stroke:#ef6c00
    style F fill:#0e2e10,stroke:#2e7d32
    style G fill:#0e2e10,stroke:#2e7d32

\n## The Unfolded Protein Response: Three Signaling Arms

The endoplasmic-reticulum-stress is coordinated by three ER-resident transmembrane sensor proteins: PERK (PKR-like endoplasmic reticulum kinase), IRE1alpha (“inositol-requiring enzyme 1alpha”), and ATF6 (activating transcription factor 6). Under normal conditions, all three sensors are maintained in

an inactive state through binding of the ER chaperone BiP/GRP78 to their luminal domains. When unfolded proteins accumulate, BiP dissociates from the sensors to assist in protein folding, thereby activating each pathway ^{2Citation2022 · Cell Death & DiseaseOpen reference}5 ^{2Citation2022 · Cell Death & DiseaseOpen reference}6.

PERK–eIF2α–ATF4 Pathway

PERK activation is initiated by BiP dissociation and subsequent oligomerization and trans-autophosphorylation of the PERK kinase domain. Active PERK phosphorylates eukaryotic initiation factor 2α (eIF2α) at serine 51, which dramatically reduces global cap-dependent mRNA translation, thereby decreasing the protein load entering the ER. Paradoxically, p-eIF2α selectively enhances translation of specific mRNAs containing upstream open reading frames (uORFs), most notably ATF4 (activating transcription factor 4). ATF4 is a transcription factor that upregulates genes involved in amino acid metabolism, redox homeostasis, and autophagymechanisms/autophagy) ^{2Citation2022 · Cell Death & DiseaseOpen reference}7 ^{2Citation2022 · Cell Death & DiseaseOpen reference}8.

Under prolonged stress, ATF4 induces expression of CHOP (C/EBP homologous protein, also known as DDIT3/GADD153), a transcription factor that promotes apoptosis by downregulating the anti-apoptotic protein Bcl-2, upregulating pro-apoptotic BH3-only proteins (Bim, PUMA), and increasing expression of GADD34, which dephosphorylates eIF2α to restore translation—creating a vicious cycle of increased protein load in an already stressed ER. CHOP also upregulates ER oxidase ERO1α, increasing oxidative-stress production within the ER lumen ^{2Citation2022 · Cell Death & DiseaseOpen reference}9 ^{3''2017Open reference}0.

The PERK pathway has been identified as particularly important in neurodegeneration, giving rise to the concept of “PERK-opathies”—diseases driven primarily by dysregulation of the PERK signaling axis. Mutations in PERK itself cause Wolcott-Rallison syndrome, which includes neurological features, while downstream effectors of PERK signaling are implicated across multiple neurodegenerative conditions ^{3''2017Open reference}1.

IRE1α–XBP1 Pathway

IRE1α is the most evolutionarily conserved endoplasmic-reticulum-stress sensor. Upon activation, IRE1α dimerizes and undergoes trans-autophosphorylation, activating its cytoplasmic endoribonuclease (RNase) domain. The RNase domain performs an unconventional splicing reaction on XBP1 mRNA, removing a 26-nucleotide intron to generate the spliced form XBP1s. XBP1s is a potent transcription factor that upregulates genes encoding ER chaperones (BiP, GRP94, calreticulin), components of ER-associated degradation (ERAD), and phospholipid synthesis enzymes that expand ER membrane capacity ^{3''2017Open reference}2 ^{3''2017Open reference}3.

Under chronic stress, the IRE1α RNase domain also performs regulated IRE1-dependent decay (RIDD) of mRNAs, including those encoding ER-targeted proteins. While RIDD initially reduces ER protein load, excessive RIDD can degrade mRNAs encoding essential proteins and microRNAs that repress pro-apoptotic factors, thereby promoting cell death. Additionally, activated IRE1α recruits TRAF2 (TNF receptor-associated factor 2), which activates the ASK1–JNK (c-Jun N-terminal kinase) cascade, linking ER stress to inflammatory signaling through nf-kb and apoptosis through mitochondrial pathways ^{3''2017Open reference}4 ^{3''2017Open reference}5.

ATF6 Pathway

ATF6 exists as two isoforms (ATF6α and ATF6β). Under ER stress, ATF6 translocates from the ER to the Golgi apparatus, where it is sequentially cleaved by site-1 protease (S1P) and site-2 protease (S2P)—the same proteases involved in cholesterol metabolism regulation. The cleaved N-terminal cytoplasmic fragment (ATF6f) translocates to the nucleus, where it activates transcription of ER chaperone genes (BiP, GRP94), ERAD components, and XBP1 (amplifying the IRE1α pathway). ATF6α also induces DAPK1 (death-associated protein kinase 1) and CHOP, contributing to pro-apoptotic signaling under sustained stress ^{3''2017Open reference}6 ^{3''2017Open reference}7.

ER-Associated Degradation (ERAD)

ERAD is a critical protein quality control mechanism that identifies terminally misfolded proteins in the ER, retrotranslocates them to the cytoplasm through the Sec61 translocon or Derlin channels, and targets them for degradation by the ubiquitin-proteasome-system. The ERAD machinery includes recognition lectins (OS-9, XTP3-B), retrotranslocation channel components (Hrd1, SEL1L, Derlin-1/2/3), ubiquitin ligases (Hrd1, gp78, MARCH6), the p97/VCP AAA-ATPase that provides the mechanical force for extraction, and deglycosylation enzymes (PNGase) ^{3''2017Open reference}8.

Dysfunction of ERAD components has been directly linked to neurodegeneration. Mutations in VCP/p97 cause inclusion body myopathy with Paget disease and Frontotemporal Dementia (IBMPFD), and Hrd1 deficiency in mice leads to neuronal loss. Notably, disease-associated misfolded proteins such as expanded polyglutamine repeats and mutant SOD1 can physically clog the ERAD machinery, creating a feedforward loop of ER stress amplification ^{3''2017Open reference}9.

ER Stress in Specific Neurodegenerative Diseases

Alzheimer’s Disease

ER stress is deeply intertwined with alzheimers pathogenesis at multiple levels. Postmortem AD brains show significantly elevated levels of endoplasmic-reticulum-stress activation markers including p-PERK, p-eIF2α, p-IRE1α, ATF4, and CHOP, with levels correlating with Braak stage (neurofibrillary tangle burden) and preceding overt neurodegeneration. The psen1 and psen2 mutations that cause familial AD directly perturb ER calcium homeostasis by functioning as ER calcium leak channels, and mutations reduce this leak function, leading to ER calcium overload and impaired chaperone activity ^{4Citation2019Open reference}0 ^{4Citation2019Open reference}1.

amyloid-beta oligomers trigger ER stress through multiple mechanisms: direct interaction with ER membranes, disruption of ER calcium stores via ryanodine-receptor and IP3 receptor sensitization, and impairment of ERAD function. tau-protein hyperphosphorylation] is both a cause and consequence of ER stress—p-PERK co-localizes with p-tau] in AD neurons, and the PERK–gsk3-beta axis directly phosphorylates tau protein], while aggregated tau impairs ERAD by interacting with the proteasomal machinery ^{4Citation2019Open reference}2.

Parkinson’s Disease

In parkinsons, α-synuclein oligomers and aggregates trigger ER stress by multiple mechanisms. Wild-type α-synuclein directly binds to BiP/GRP78 in the ER lumen, and A53T mutant α-synuclein shows enhanced ER localization and greater endoplasmic-reticulum-stress activation. α-Synuclein oligomers block ER-to-Golgi vesicular transport by binding to Rab1 GTPase, causing accumulation of cargo proteins within the ER. Dopaminergic neurons in the substantia-nigra are particularly susceptible to ER stress due to the oxidative burden of dopamine metabolism, which generates reactive quinones that modify ER-resident proteins ^{4Citation2019Open reference}3 ^{4Citation2019Open reference}4.

The pink1/prkn mitochondrial quality control pathway intersects with ER stress through mitochondria-associated ER membranes (MAMs)—physical contact sites where mitochondria and ER exchange calcium, lipids, and signaling molecules. PINK1 and Parkin regulate MAM integrity, and their loss-of-function disrupts ER-mitochondrial calcium transfer, contributing to both ER stress and mitochondrial-dysfunction. lrrk2 mutations, the most common genetic cause of PD, also activate the PERK pathway through mechanisms involving impaired vesicular trafficking ^{4Citation2019Open reference}5.

Amyotrophic Lateral Sclerosis

Motor neurons are extraordinarily susceptible to ER stress due to their extreme morphological polarization (axons can be >1 meter long), high secretory demand, and limited endoplasmic-reticulum-stress capacity. In als, mutant sod1-protein protein mislocalizes to the ER lumen, where it interacts with BiP and Derlin-1, directly engaging and overwhelming the endoplasmic-reticulum-stress machinery. tdp-43 pathology, present in ~97% of ALS cases, disrupts ER function by altering mRNA processing of ERAD components and ER chaperones. fus mutations impair stress granule dynamics that normally sequester translationally stalled mRNAs during ER stress, creating aberrant persistent stress granules that evolve into pathological inclusions ^{4Citation2019Open reference}6 ^{4Citation2019Open reference}7.

c9orf72 repeat expansions, the most common genetic cause of ALS/FTD, produce dipeptide repeat (DPR) proteins through repeat-associated non-AUG (RAN) translation that accumulate in the ER and activate all three endoplasmic-reticulum-stress arms. The arginine-containing DPRs (poly-GR, poly-PR) are particularly toxic and impair nucleocytoplasmic transport, further disrupting the cellular stress response ^{4Citation2019Open reference}8.

Huntington’s Disease

Mutant huntingtin protein] with expanded polyglutamine tracts is processed through the ER and can form oligomeric intermediates that sequester ER chaperones, deplete BiP availability, and activate the endoplasmic-reticulum-stress. The expanded polyQ tract also impairs ERAD by physically obstructing the retrotranslocation channel. In huntington-pathway models, PERK and IRE1α pathways are activated early and correlate with disease progression. XBP1s overexpression in HD mouse models is neuroprotective, while CHOP deletion delays disease onset ^{4Citation2019Open reference}9 ^{5Citation2026Open reference}0.

Prion Disease

prion-diseases represent a particularly instructive example of ER stress in neurodegeneration. PrPSc (misfolded prion protein) accumulates in the ER and activates the PERK pathway. Strikingly, genetic or pharmacological reduction of PERK–eIF2α signaling (using the small molecule ISRIB or eIF2α phosphatase GADD34 overexpression) rescues neuronal survival in prion-infected mice without affecting PrPSc levels, demonstrating that endoplasmic-reticulum-stress-mediated translational repression—rather than protein aggregation per se—is a direct driver of neuronal death ^{5Citation2026Open reference}1 ^{5Citation2026Open reference}2.

ER-Mitochondria Crosstalk and MAMs

Mitochondria-associated ER membranes (MAMs) are specialized membrane contact sites (10–30 nm apart) that mediate bidirectional communication between the ER and mitochondria. These contacts are critical for calcium signaling (via IP3R–VDAC–MCU complexes), phospholipid transfer, mitochondrial-dynamics (fission occurs at ER-mitochondria contact sites), autophagosome biogenesis, and inflammasome assembly. MAM dysfunction is increasingly recognized as a convergence point in neurodegeneration ^{5Citation2026Open reference}3 ^{5Citation2026Open reference}4.

In AD, presenilins are enriched at MAMs, and FAD mutations alter MAM function, leading to increased ER-mitochondria apposition and aberrant calcium transfer. apoe4 increases MAM activity compared to APOE3. [In PD, PINK1/Parkin, dj1, and α-synuclein all localize to MAMs and regulate contact site dynamics. In ALS, tdp-43 and FUS disruptions alter MAM-mediated calcium flux. These findings suggest that ER-mitochondria contact site dysfunction represents a shared upstream mechanism across neurodegenerative diseases ^{5Citation2026Open reference}5.

ER Stress and neuroinflammation

ER stress activates inflammatory signaling through multiple mechanisms, connecting proteostasis failure to neuroinflammation. The IRE1α–TRAF2 complex activates both nf-kb and JNK pathways, driving transcription of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). PERK–eIF2α–ATF4 signaling activates nf-kb by suppressing translation of its inhibitor IκBα (which has a shorter half-life than nf-kb and is therefore preferentially depleted during translational suppression). ER stress in microglia and astrocytes amplifies the inflammatory response through cell-non-autonomous mechanisms: stressed microglia release pro-inflammatory mediators that further stress neighboring neurons, creating a feedforward inflammatory cascade link.

The nlrp3-inflammasome is activated downstream of ER stress through IRE1α–TXNIP signaling. TXNIP (thioredoxin-interacting protein) is induced by IRE1α-mediated RIDD of miR-17, which normally suppresses TXNIP expression. Elevated TXNIP activates the nlrp3-inflammasome inflammasome, leading to caspase-1 activation, IL-1β and IL-18 maturation and release, and pyroptotic cell death ^{5Citation2026Open reference}6.

Therapeutic Strategies Targeting ER Stress

Chemical Chaperones

4-Phenylbutyric acid (4-PBA) and tauroursodeoxycholic acid (TUDCA) are FDA-approved chemical chaperones that stabilize protein folding in the ER and reduce endoplasmic-reticulum-stress activation. TUDCA has shown neuroprotective effects in preclinical models of AD, PD, ALS, and HD, and a combination of TUDCA with sodium phenylbutyrate (AMX0035/Relyvrio) was temporarily approved for ALS treatment, though it was later withdrawn after a Phase 3 trial failed to confirm efficacy ^{5Citation2026Open reference}7 ^{5Citation2026Open reference}8.

PERK Pathway Modulators

GSK2606414, a selective PERK inhibitor, rescues neurodegeneration in prion-diseased mice but causes pancreatic toxicity. ISRIB (integrated stress response inhibitor) acts downstream of eIF2α phosphorylation by stabilizing eIF2B in its active conformation, restoring translation without blocking the upstream adaptive PERK response. ISRIB has shown promise in multiple neurodegenerative disease models and is a lead compound for clinical development ^{5Citation2026Open reference}9 ^{6Citation2023 · Life SciencesOpen reference}0.

IRE1α Modulators

Small molecules that selectively modulate IRE1α RNase activity (e.g., STF-083010, 4μ8c) can inhibit pathological RIDD while preserving beneficial XBP1 splicing, though achieving this selectivity in vivo remains challenging. Alternatively, gene therapy approaches to overexpress XBP1s have shown neuroprotection in models of PD, ALS, and HD ^{6Citation2023 · Life SciencesOpen reference}1.

Targeting ER Calcium Homeostasis

Dantrolene, a ryanodine-receptor antagonist, reduces ER calcium leak and attenuates ER stress in AD models. IP3 receptor modulators and SERCA pump activators are also under investigation as approaches to normalize ER calcium stores and reduce stress-induced calcium transfer to mitochondria ^{6Citation2023 · Life SciencesOpen reference}2.

Clinical Trials and Biomarkers

Clinical Trials Targeting ER Stress

Several therapeutic approaches targeting ER stress have advanced to clinical testing for neurodegenerative diseases.

AMX0035 (Relyvrio) — AMX0035 was a co-formulation of sodium phenylbutyrate and tauroursodeoxycholic acid (TUDCA) designed to reduce ER stress and mitochondrial dysfunction in ALS. The drug received FDA approval in 2022 based on Phase 2 trial data showing reduced functional decline ^{6Citation2023 · Life SciencesOpen reference}3. However, the Phase 3 CHAMPION-ALS trial (NCT05021536) completed in 2024 and did not meet its primary endpoint, leading to voluntary withdrawal of the drug from the market in October 2024 ^{6Citation2023 · Life SciencesOpen reference}4.

TUDCA Monotherapy Studies — TUDCA has been evaluated in multiple clinical trials for neurodegenerative diseases:

• A Phase 2 trial in ALS (NCT00877604) showed trends toward reduced functional decline but was not powered for efficacy ^{6Citation2023 · Life SciencesOpen reference}5

• An observational study in Parkinson’s disease (NCT01123395) suggested potential neuroprotective effects ^{6Citation2023 · Life SciencesOpen reference}6

• Studies in Alzheimer’s disease have explored TUDCA’s effects on biomarkers of ER stress and neuronal damage ^{6Citation2023 · Life SciencesOpen reference}7

ISRIB Development — ISRIB (integrated stress response inhibitor) has advanced to Phase 1 clinical trials for potential use in neurodegenerative diseases. By stabilizing eIF2B and restoring protein synthesis despite eIF2α phosphorylation, ISRIB represents a novel approach to modulating the UPR ^{6Citation2023 · Life SciencesOpen reference}8.

Biomarkers of ER Stress

Biomarkers for monitoring ER stress in clinical settings include:

Molecular Biomarkers:

• CHOP (DDIT3) expression — elevated in neurons undergoing ER stress-induced apoptosis

• XBP1 splicing — measurable in peripheral blood mononuclear cells as a marker of IRE1α pathway activation

• ATF4 target genes — including GADD34, CHOP, and other components of the pro-apoptotic transcriptional program

Proteomic Biomarkers:

• GRP78/BiP (HSPA5) — ER chaperone released during severe ER stress

• caspase-12 activation — specifically activated by ER-resident caspases in human neurons

• phospho-PERK and phospho-eIF2α — detectable in cerebrospinal fluid and brain tissue ^{6Citation2023 · Life SciencesOpen reference}9

CSF Biomarkers:

• Total tau and phosphorylated tau — correlate with ER stress in AD

• Neurofilament light chain (NfL) — elevated in conditions with significant neuronal ER stress

• YKL-40 (CHI3L1) — marker of neuroinflammation linked to ER stress responses ^{7''Open reference}0

Patient Impact and Clinical Relevance

ER stress biomarkers have shown clinical utility in:

• Prognostic stratification — Elevated CHOP and XBP1 splicing in peripheral cells correlate with disease severity in ALS and PD

• Treatment response monitoring — Changes in GRP78 levels may predict response to chemical chaperone therapy

• Disease progression tracking — CSF YKL-40 and NfL levels track with ER stress-mediated neurodegeneration

Understanding a patient’s ER stress status can inform therapeutic decisions, particularly regarding the use of chemical chaperones or UPR modulators.

Emerging Concepts and Future Directions

Cell-Non-Autonomous ER Stress

Recent research reveals that ER stress responses are not cell-autonomous but can be transmitted between cells. neurons and glia communicate stress states through secreted factors, exosomes, and direct contact, coordinating tissue-level proteostasis networks. In C. elegans, neuronal XBP1s cell-non-autonomously activates endoplasmic-reticulum-stress in peripheral tissues, and analogous mechanisms are being identified in mammalian systems. This intercellular endoplasmic-reticulum-stress signaling may explain the stereotyped patterns of disease propagation observed in neurodegenerative diseases ^{7''Open reference}1.

ER-phagy

ER-phagy (reticulophagy) is a selective form of autophagymechanisms/autophagy) that targets damaged ER for lysosomal degradation, serving as a last-resort quality control mechanism when ERAD and the endoplasmic-reticulum-stress are insufficient. ER-phagy receptors (FAM134B, SEC62, RTN3, CCPG1, ATL3, TEX264) are differentially expressed in neuronal subtypes and may contribute to selective-neuronal-vulnerability. Mutations in FAM134B cause hereditary sensory and autonomic neuropathy type II (HSAN2), directly linking ER-phagy failure to neurodegeneration ^{7''Open reference}2.

Integrated Stress Response

The integrated stress response (ISR) integrates signals from multiple stress pathways—ER stress (PERK/HRI), amino acid deprivation (GCN2), viral infection (PKR), and heme deficiency (HRI)—all converging on eIF2α phosphorylation. This convergence means that non-ER stresses can amplify the ER stress response, and ISR modulators like ISRIB may have broader therapeutic applications than pathway-specific inhibitors ^{7''Open reference}3 ^{7''Open reference}4.

See Also

• [All Mechanisms

Background

The study of Endoplasmic Reticulum Stress In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Recent Research Updates (2024-2026)

Recent publications advancing understanding of endoplasmic reticulum stress mechanisms in neurodegenerative diseases.

• 2025: Adaptive inter-tissue proteostasis networks in aging and neurodegeneration. (Bioscience Reports) — Examines how ER stress signaling coordinates across tissues in aging and neurodegenerative disease.

• 2024: PERK pathway modulation as a therapeutic strategy in Alzheimer’s disease. (Nat Rev Neurosci) — Reviews PERK-eIF2α signaling as a target for AD therapy.

• 2025: The unfolded protein response in Parkinson’s disease: From pathogenesis to treatment. (Cell Death Dis) — Links ER stress to alpha-synuclein toxicity in PD models.

• 2024: TRAF2-mediated apoptosis in ER stress-induced neurodegeneration. (Cell Rep) — Demonstrates TRAF2 role in ER stress-induced neuronal death.

• 2025: XBP1 splicing and cognitive function in aging and Alzheimer’s disease. (Neuron) — Shows XBP1 deficiency promotes amyloid pathology and cognitive decline.

ER Stress Comparison Across Neurodegenerative Diseases

This comparison table highlights how different neurodegenerative diseases engage distinct aspects of the UPR, with PERK pathway activation being most prevalent across AD, ALS, and prion diseases, while IRE1α-XBP1 signaling is prominent in PD.

^{7''Open reference}5: Paganoni S et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. New England Journal of Medicine. 2022;387(5):421-432.

^{7''Open reference}6: Amylyx Pharmaceuticals. AMX0035 Phase 3 CHAMPION-ALS Trial Results. ClinicalTrials.gov NCT05021536. 2024.

^{7''Open reference}7: Bowling AC et al. Tauroursodeoxycholic acid (TUDCA) for ALS: phase 2 trial results. Journal of the Neurological Sciences. 2015;351:S51-S52.

^{7''Open reference}8: Lebovitz C et al. A randomized, double-blind, placebo-controlled trial of TUDCA in Parkinson’s disease. Movement Disorders. 2020;35(7):1235-1244.

^{7''Open reference}9: Ionescu-Tucker A et al. ER stress in Alzheimer’s disease: therapeutic implications. Journal of Alzheimer’s Disease. 2022;85(2):557-572.

^{8Citation2023 · PMID 38159591Open reference}0: Wong YL et al. ISRIB, a small molecule integrator of the integrated stress response. Drug Discovery Today. 2019;24(10):2076-2087.

^{8Citation2023 · PMID 38159591Open reference}1: Ito Y et al. Cerebrospinal fluid GRP78 as a biomarker for ER stress in neurodegenerative diseases. Molecular Neurobiology. 2020;57(2):1043-1054.

^{8Citation2023 · PMID 38159591Open reference}2: Choi JY et al. YKL-40 in the CSF and serum of patients with neurodegenerative diseases. Journal of Neuroimmunology. 2021;361:577614.

Confidence Assessment

🔴 Low Confidence

Overall Confidence: 34%

^{8Citation2023 · PMID 38159591Open reference}3: [Reference missing - citation needed]

^{8Citation2023 · PMID 38159591Open reference}4: [Reference missing - citation needed]

^{8Citation2023 · PMID 38159591Open reference}5: [Reference missing - citation needed]

^{8Citation2023 · PMID 38159591Open reference}6: [Reference missing - citation needed]

^{8Citation2023 · PMID 38159591Open reference}7: [Reference missing - citation needed]

^{8Citation2023 · PMID 38159591Open reference}8: [Reference missing - citation needed]

^{8Citation2023 · PMID 38159591Open reference}9: [Reference missing - citation needed]

^{1Citation2015Open reference}0: [Reference missing - citation needed]